
During a live event, Pedro Barata, MD, MSc, and participating oncologists discussed how efficacy, tolerability, and clinical evidence inform subsequent-line treatment selection for metastatic clear cell renal cell carcinoma.
Therapeutic Approach for Metastatic Renal Cell Carcinoma
Case Scenario: A 73-year old female with rapidly progressing mRCC
March 2017
December 2017